
The all-cash deal gives Kirin a North American supplements platform through Jamieson Wellness, with closing targeted from the fourth quarter of 2026. Photo by White.Rainforest ™︎ ∙ 易雨白林. on Unsplash
White.Rainforest ™︎ ∙ 易雨白林.
Kirin Holdings said on August 7 it had signed an agreement to acquire 100% of the outstanding shares of Canada’s Jamieson Wellness Inc. for C$45.75 per share in cash, in a deal valued at C$1.898 billion, as the Japanese brewer and healthcare group seeks to build a North American base for its health science business.
The transaction will be carried out through a Plan of Arrangement under Canadian corporate law, a process used to acquire all shares of a listed Canadian company. Kirin said the structure would allow it to acquire all of Jamieson Wellness’s shares, including those held by shareholders who oppose the deal or do not vote, subject to court approval and other conditions.
Jamieson Wellness shareholders must approve the transaction at a shareholder meeting by at least a two-thirds majority of votes cast. The deal may also require approval by a simple majority of votes cast excluding certain related parties. Jamieson Wellness’s board approved the transaction on August 6, Canada time, while Kirin’s decision was made on August 7, Japan time.
If the acquisition proceeds as planned, Kirin expects to complete it in or after the fourth quarter of 2026. After completion, Kirin would own 41,490,939 shares, or 100% of the voting rights, up from zero before the transaction.
Jamieson Wellness, founded in 1922 and based in Toronto, manufactures, distributes and sells vitamins, minerals and supplements products mainly in North America. Kirin said the company has the top market share in Canada’s supplement market and has strengthened its U.S. presence through the 2022 acquisition of Nutrawise Health & Beauty Corporation, centered on the youtheory brand.
Jamieson Wellness posted revenue of C$530 million for the year ended December 2025, compared with C$548 million in 2024 and C$481 million in 2023. Total assets stood at C$1.215 billion at the end of 2025. Mackenzie Financial Corporation is Jamieson Wellness’s largest shareholder, with an 11.8% stake.
Kirin said the acquisition is intended to establish a business platform in North America, which it described as the world’s largest supplement market, and to strengthen the global growth base of its health science business. The company has expanded that business through acquisitions including Australia-based Blackmores and Japanese cosmetics and supplements company Fancl, and in 2026 set up Kirin Health Science International to integrate brands, sales networks, research and development, and marketing capabilities across the group.
Kirin said it expects synergies from combining the two companies’ assets and capabilities, including broader geographic reach and customer touchpoints through shared sales networks, product development using high-value-added ingredients, stronger research and product development, procurement efficiencies and a more optimized operating structure.
Japan’s large consumer goods groups have increasingly used overseas acquisitions to expand healthcare and supplements operations as domestic beer demand remains mature. For Kirin, the Jamieson acquisition would add a direct operating foothold in Canada and the United States to a health science portfolio that has already been built out in Asia and Oceania.